Related Tags >> Cephalon FDA FDA approval Biogen Idec

Provigil News

Most Popular Provigil Story

ALSO NOTED: ZymoGenetics to chop jobs; Evotec extends collaboration; Iomai touts results for vaccine patch; and much more...

February 14, 2008 — 7:59am ET

> ZymoGenetics is chopping 80 jobs--mostly in R&D--after facing some tough reviews for the potential of its newly released drug Recothrom--a genetically engineered form of thrombin to prevent... Read more...

Latest Headlines

ALSO NOTED: ZymoGenetics to chop jobs; Evotec extends collaboration; Iomai touts results for vaccine patch; and much more...
February 14, 2008
FDA review may force extension of Nuvigil deadline
December 6, 2006
Cephalon shares tank after Sparlon rejection
August 9, 2006
ALSO NOTED: Companies compete for microdosing tests; Bayer to expand facility; and much more...
June 12, 2006
FDA issues approvable letter for Nuvigil
May 1, 2006
FTC criticizes delay of generic competition
April 24, 2006
ALSO NOTED: Investors back Sequenom; Inspire meets with FDA; and much more...
March 27, 2006
FDA staffers question safety of Sparlon for ADHD
March 21, 2006
Cephalon shares surge on generic pact
February 1, 2006
ALSO NOTED: FDA extends YAZ review; Rastetter to retire from Biogen Idec; Tamoxifen may help boys grow taller;and much more...
December 8, 2005
Cephalon wins approvable letter for new ADHD therapy
October 20, 2005
Provigil study sparks debate over ability to enhance alertness
August 3, 2005
Alkermes inks rich collaboration deal for Vivitrex
June 23, 2005

Paid Research Reports